5-Aminosalicylic Acid in the Treatment of Crohn's Disease: A 16-Week Double-Blind, Placebo-Controlled, Multicentre Study with Pentasa®

1987 ◽  
Vol 22 (7) ◽  
pp. 877-883 ◽  
Author(s):  
S. N. Rasmussen ◽  
K. Lauritsen ◽  
U. Tage-Jensen ◽  
O. H. Nielsen ◽  
P. Bytzer ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Multicentre Study ◽  
Aminosalicylic Acid ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Tu1716 – Highly Bioavailable Curcumin (Theracurmin®) for Crohn's Disease: Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial

2019 ◽  
Vol 156 (6) ◽  
pp. S-1096 ◽  
Author(s):  
Ken Sugimoto ◽  
Kentaro Ikeya ◽  
Shigeki Bamba ◽  
Akira Andoh ◽  
Hiroshi Yamasaki ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn’s Disease

2016 ◽  
Vol 111 (11) ◽  
pp. 1599-1607 ◽  
Author(s):  
Stephan R Targan ◽  
Brian Feagan ◽  
Severine Vermeire ◽  
Remo Panaccione ◽  
Gil Y Melmed ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Phase 2 ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Phase 2 Study

scholarly journals Double blind, placebo controlled trial of metronidazole in Crohn's disease.

Gut ◽  
1991 ◽  
Vol 32 (9) ◽  
pp. 1071-1075 ◽  
Author(s):  
L Sutherland ◽  
J Singleton ◽  
J Sessions ◽  
S Hanauer ◽  
E Krawitt ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document